Vimarsana
Biggest News Aggregation in the World

Page 49 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Lonza's softgel interests wane with sale of European sites - Vimarsana News

Lonza's softgel interests wane with sale of European sites

Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets. The production sites in Ploermel in France and Edinburgh in the UK, employs around 260 and 130 permanent staff respectively and produces liquid-filled hard capsules (including Licaps) and softgels (including for high potent and hormonal products). “NextPharma is an established and well-respected company, with extensive experience in oral and topical finished...

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content - Vimarsana News

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content USA - English Share this article accelerate innovation by bringing life-saving medicines to patients faster LONDON, Jan. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis CMC Intelligence™, the world's only organized, timely and accurate source of Chemistry, Manufacturing and Controls (CMC) regulations and local practices. The addition of new b...

Lonza Group AG: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms - Vimarsana News

Lonza Group AG: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms

(2) NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage forms Centers of excellence employing a total of 390 staff offer expertise in Lipid Oral Dosage Forms including softgels and liquid-filled hard capsules for the pharma and nutrition markets Sustainable growth and people development a priority for both companies A French version of this release is also available Quote from Gordon Ba...

Fine Pharmaceutical Chemicals Market Major Manufacturers, Trends, Sales, Supply, Demand, Share Analysis to 2026 - Vimarsana News

Fine Pharmaceutical Chemicals Market Major Manufacturers, Trends, Sales, Supply, Demand, Share Analysis to 2026

Fine Pharmaceutical Chemicals Market Major Manufacturers, Trends, Sales, Supply, Demand, Share Analysis to 2026

Ulcerative Colitis Market Research by Size, Top Leading Countries, Consumption, Drivers, Trends, For - Vimarsana News

Ulcerative Colitis Market Research by Size, Top Leading Countries, Consumption, Drivers, Trends, For

Search jobs 24-Dec-2020 Ulcerative Colitis Market Research by Size, Top Leading Countries, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges, Top Companies-Allergan, AbbVie, Bayer AG, UCB S.A DBMR has launched a new market report titled Global Ulcerative Colitis Market Size, Share, Industry Trends and Forecast to 2027 which is an output of a brief assessment and an all-inclusive analysis of the market’s key factors. The study covers details of market size, share, trends, growth spectrum, and the competitive scenario of the globa...